Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Journal of Clinical Medicine|November 13, 2021
Mechanical Ventilation during Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome: A Narrative ReviewLi-Chung Chiu, Kuo-Chin KaoClinical Immunology (Orlando, Fla.)|January 16, 2026
Clinical prognosis and cancer risk assessment in autoimmune diseases with anti-TIF1γ alone or concurrent with anti-Ro52 antibodies in a Taiwanese cohortChih-Chun Lee, Li-Chung Chiu, Shih-Ching Lee, et al.Frontiers in Immunology|October 9, 2023
Case Report: High-dose steroid and IVIG successful treatment in a case of COVID-19-associated autoimmune encephalitis: a literature reviewChi-Hung Liu, Li-Chung Chiu, Chih-Chun Lee, et al.Annals of Work Exposures and Health|July 8, 2026
Temporal effects of educational interventions on fit and knowledge retention of N95 filtering facepiece respirator under rest and exertionHsin-Hsien Li, Li-Chung Chiu, Hsuan-I Weng, et al.Clinical Rheumatology|July 15, 2025
Coexistence of anti-melanoma differentiation-associated protein 5 and anti-Ro52 antibodies in patients with idiopathic inflammatory myopathy: a retrospective cohort studyYu Chen, Yen-Fu Chen, Li-Chung Chiu, et al.Journal of Personalized Medicine|March 25, 2022
Relationship between Mechanical Ventilation and Histological Fibrosis in Patients with Acute Respiratory Distress Syndrome Undergoing Open Lung BiopsyHsin-Hsien Li, Chih-Wei Wang, Chih-Hao Chang, et al.Plos One|July 6, 2017
Survival predictor in patients with acute respiratory distress syndrome and diffuse alveolar damage undergoing open lung biopsyKuo-Chin Kao, Chih-Hao Chang, Chen-Yiu Hung, et al.Journal of Aerosol Medicine and Pulmonary Drug Delivery|May 23, 2023
Predicting Inhaled Drug Dose Generated by Mesh NebulizersYu-Chung Hsu, Hsin-Hsien Li, Li-Chung Chiu, et al.Vaccines|July 2, 2021
Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)Li-Chung Chiu, Shu-Min Lin, Yu-Lun Lo, et al.Vaccines|October 26, 2021
Durvalumab as Consolidation Therapy in Post-Concurrent Chemoradiation (CCRT) in Unresectable Stage III Non-Small Cell Lung Cancer Patients: A Multicenter Observational StudyChin-Chou Wang, Li-Chung Chiu, Jia-Shiuan Ju, et al.Pageof 6